Imeglimin
2 Inquiries
775351-65-0
Hyderabad
1kg
2022-01-01
Rabeprazole,Omeprazole,Silodosin,Levocetririzine
-
Product Description
-
Seller Information
-
Inquiry History
-
DescriptionECHEMI Editorial ReferenceImeglimin has been used in trials studying the treatment of Type 2 Diabetes Mellitus.
Imeglimin is an oral anti-diabetic drug discovered by Poxel and co-developed with Sumitomo Dainippon Pharma. In 2021, Imeglimin was approved in Japan for the treatment of type 2 diabetes (T2D).Basic Info-
Product Name:
Imeglimin
Other Name:1,3,5-Triazine-2,4-diamine,1,6-dihydro-N,N,6-trimethyl-,(+)-(9CI);IMegliMin;EMD 387008;R-IMegliMin;EMD 387008/R-Imeglimin;EMD 387008 (R-IMEGLIMIN) HCL;1,3,5-Triazine-2,4-diamine, 3,6-dihydro-N2,N2,6-trimethyl-, (6R)-;Emd 387008 hcl
CAS No.:775351-65-0
Molecular Formula:C6H13N5
InChIKeys:InChIKey=GFICWFZTBXUVIG-SCSAIBSYSA-N
Molecular Weight:155.2
Exact Mass:155.20
UNII:UU226QGU97
DSSTox ID:DTXSID50228237
Categories:
Characteristics-
Density:
1.29±0.1 g/cm3(Predicted)
Boiling Point:239.9±23.0 °C(Predicted)
PKA:11.65±0.40(Predicted)
Critical Temperature & Pressure:Store at -20°C
Hazard IdentificationClassification of the substance or mixture
no data available
GHS label elements, including precautionary statements
Pictogram(s) no data available Signal word no data available
Hazard statement(s) no data available
Precautionary statement(s) Prevention no data available
Response no data available
Storage no data available
Disposal no data available
Other hazards which do not result in classification
no data available
Handling and StoragePrecautions for safe handling
Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.
Conditions for safe storage, including any incompatibilities
Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.
-
-
Seller Information
-
Business Type:
Manufactory
-
Main Products:
Rabeprazole,Omeprazole,Silodosin,Levocetririzine
-
Location:
Bhanu Enclave, No 302, above Hero Showroom, Sundar Nagar, Erragadda, Hyderabad, Telangana 500038
-
Payment Terms:
TT against copy of documents,D/P,L/C,D/A,O/A
-
Average lead Time:
365 days
-
Total Annual Revenue:
Above $100 million
-
Total Employees:
Above 1000
-
Year of Establishment:
2002
-
-
Inquiry History2 Inquiries
Country Product Purchase Quantity Date Posted 
France
Imeglimin
25 KG Nov 28, 2023 
India
Imeglimin
400 KG Feb 13, 2025 Post an enquiry for this product
